Kidney Transplant Success Rate in India (2026): Complete Data by Age, Donor Type, Hospital and Year
Filters & Insights
What is the kidney transplant success rate in India? Read data by age group, donor type, hospital and year. Book Free consultation Now!
For any patient considering a kidney transplant abroad, one question matters above all others: what are the chances of success? Everything else, cost, hospitals, travel, recovery, only makes sense once you are confident that the medical outcome is likely to be positive.
India performs over 9,000 kidney transplants every year, making it the second largest kidney transplant programme in the world after the United States. And the question of success rates has a clear, data-backed answer: at India’s leading transplant centres, the one-year survival rate for living donor kidney transplants is 92 to 96 percent, a figure that directly matches published benchmarks from the International Society of Nephrology and sits within the range reported by leading transplant centres in the USA, UK, and Europe.
But a single headline number does not tell the full story. Success rates vary meaningfully depending on the type of donor (living or deceased), the patient’s age, the cause of kidney failure, the hospital and surgeon performing the procedure, and the quality of post-transplant care. This guide provides the most detailed, data-driven breakdown of kidney transplant success rates in India available online, giving you the specific numbers relevant to your situation.
It also explains the clinical factors that drive these outcomes and why India’s high-volume transplant centers consistently match global standards, so you can make an informed, confident decision.
Kidney Transplant Success Rate in India: Overall Data (2026)
| Success Rate Metric | Data (India’s Leading Centres) |
|---|---|
| 1-Year Graft Survival (Living Donor) | 92% – 96% |
| 1-Year Graft Survival (Deceased Donor) | 85% – 90% |
| 1-Year Patient Survival (Living Donor) | 95% – 98% |
| 1-Year Patient Survival (Deceased Donor) | 88% – 92% |
| 3-Year Graft Survival (Living Donor) | 85% – 90% |
| 5-Year Graft Survival (Living Donor) | 75% – 85% |
| 5-Year Graft Survival (Deceased Donor) | 65% – 75% |
| 10-Year Graft Survival | 55% – 65% (high-volume centres) |
| Paediatric Transplant (1 Year) | Up to 97% |
| Re-Transplant (1 Year) | 85% – 90% |
| ABO-Incompatible (1 Year) | 88% – 93% |
| Global Benchmark (ISN) | 90% – 95% (India matches or exceeds) |
Important: These figures represent outcomes at India’s JCI-accredited, high-volume transplant centers. Outcomes at lower-volume or non-accredited facilities may vary. The hospitals specifically cited in the hospital-by-hospital section below all fall within or above these ranges. Shifam Health partners exclusively with accredited, high-volume centers.
Explore:- Top 10 Cheapest Countries for Kidney Transplant (Cost, Safety & Success Rate Comparison Guide)
Success Rate by Donor Type: Living Donor vs Deceased Donor
The type of donor is the single biggest factor influencing kidney transplant success in India. Understanding why this matters helps patients make better decisions about their donor situation before travelling.
| Factor | Living Donor vs Deceased Donor |
|---|---|
| 1-Year Graft Survival | Living: 92–96% Deceased: 85–90% |
| 5-Year Graft Survival | Living: 75–85% Deceased: 65–75% |
| Cold Ischaemia Time | Living: Near zero (immediate transplant) Deceased: Several hours (organ preservation delay) |
| Graft Quality | Living: Healthy, screened donor Deceased: Variable quality |
| Delayed Graft Function | Living: Very low (<5%) Deceased: Higher (20–30%) |
| Waiting Time | Living: No wait (scheduled) Deceased: Months to years |
| Availability (International Patients) | Living: Available in India Deceased: Generally not available |
| Why Living Donor is Preferred | Better outcomes, fresher organs, no waiting time — making living donor transplant the gold standard in India. |
A published study in the Indian Journal of Nephrology reported patient survival of 98.7 percent at 3 years for living donor kidney transplants at a leading South Indian centre. This figure exceeds the global ISN benchmark and reflects the outcome quality achievable at India’s highest-volume transplant centres.
Kidney Transplant Success Rate by Age Group in India
Age is one of the most commonly asked-about variables in kidney transplant success. Here is the data by age group at India’s leading centres:
| Patient Age Group | Success Rate & Key Considerations |
|---|---|
| Under 18 years (Paediatric) | 1-year survival up to 97%. Requires specialised paediatric teams. Available at major centres like Apollo, Manipal, Medanta, and CMC Vellore. |
| 18 to 34 years | 1-year graft survival ~93–96%. Strong physiology but slightly higher rejection risk. Requires strict medication adherence and monitoring. |
| 35 to 49 years | 1-year graft survival ~92–95%. Best overall outcomes due to balance of health and adherence. |
| 50 to 64 years | 1-year graft survival ~88–93%. Good outcomes with careful cardiac assessment and tailored medication dosing. |
| 65 years and above | 1-year graft survival ~82–88%. Still highly beneficial vs dialysis. Requires thorough pre-transplant evaluation. |
| Donor Age Impact | Kidneys from donors under 50 provide better long-term outcomes. India’s living donor system often ensures younger, healthier donors. |
How the Cause of Kidney Failure Affects Transplant Success
The underlying condition that caused kidney failure also influences transplant success, as some conditions can recur in the transplanted kidney.
| Cause of Kidney Failure | Impact on Transplant Success |
|---|---|
| Diabetic Nephropathy | Excellent outcomes with good diabetes control. Requires strict post-transplant glucose management. |
| Hypertensive Nephropathy | Very favourable outcomes. Long-term success depends on tight blood pressure control. |
| IgA Nephropathy | Recurrence possible (~30%), but rarely affects graft survival in early years. Overall good outcomes. |
| Polycystic Kidney Disease (PKD) | No recurrence in transplanted kidney. Among the best long-term transplant outcomes. |
| Focal Segmental Glomerulosclerosis (FSGS) | Higher recurrence risk (20–40%). Requires close monitoring and specialised management. |
| Lupus Nephritis | Good outcomes if disease is controlled before transplant. Low recurrence risk (~3–4%). |
| Obstructive Nephropathy | Excellent outcomes once underlying cause is corrected. No recurrence risk. |
| Unknown / Multi-factorial | Standard outcomes. Success depends more on overall health and post-transplant care. |
Kidney Transplant Success Rate by Top Hospital in India (2026)
This is the section that no competitor blog provides. Here is published and verified success rate data for India’s leading kidney transplant centres:
Apollo Hospitals
• 20,000+ transplants
• 95%+ 1-year survival (living donor)
• Robotic transplant pioneer
• Paediatric success up to 97%
• JCI & NABH accredited
Medanta – The Medicity
• High-volume ABO-incompatible programme
• 92–95% 1-year success
• JCI accredited
Fortis Hospital
• Leading volume in North India
• 91–95% 1-year success
• JCI & NABH accredited
Manipal Hospitals
• 2,500+ transplants
• 97% pediatric success
• 92–95% adult success
• JCI & NABH accredited
Max Healthcare
• High-volume kidney transplant programme
• 92–96% 1-year success (living donor)
• Experienced nephrology & transplant teams
• NABH & JCI (select centres) accredited
Kokilaben Dhirubhai Ambani Hospital
• Advanced transplant centre
• Strong international patient care
Artemis Hospital
• ABO-incompatible & paired exchange
• 90–93% 1-year success
• JCI accredited
Factors That Influence Kidney Transplant Success Rate
Understanding what drives success rates helps patients choose the right hospital, donor, and post-transplant approach. These are the key clinical factors:
1. Donor Type and Organ Quality
Living donor kidneys consistently deliver better outcomes than deceased donor kidneys. They are fresher (zero cold ischaemia time), come from a comprehensively screened healthy individual, and have lower rates of delayed graft function. India’s predominantly living donor transplant model is itself a clinical strength.
2. HLA Matching and Crossmatch
Human Leukocyte Antigen (HLA) compatibility between donor and recipient reduces the immune system’s tendency to recognize the new kidney as foreign. India’s top centers use advanced HLA typing and virtual crossmatch technology to optimize donor-recipient matching, reducing rejection risk and improving long-term graft survival.
Also Read:- Dialysis in India: A Complete Guide to World-Class Kidney Care & Affordable Treatment
3. Surgical Volume and Expertise
Research published in major transplant journals consistently shows that higher-volume transplant centres achieve better outcomes. Surgeons and teams who perform more procedures have lower complication rates, better intraoperative decision-making, and more experience managing post-operative challenges. India’s leading centres, particularly Apollo Chennai, CMC Vellore, and Manipal, perform among the highest volumes of kidney transplants in Asia.
4. HEPA-Filtered Transplant ICUs
Post-transplant patients on immunosuppression are highly vulnerable to infection. Hospitals with dedicated transplant ICUs fitted with HEPA air filtration have significantly lower rates of post-operative infections in the critical early weeks. This infrastructure detail separates India’s premier transplant centres from lower-tier options.
5. Immunosuppressant Protocol Quality
The management of tacrolimus, mycophenolate mofetil, and prednisolone in the post-transplant period requires precision dosing guided by regular drug level monitoring. India’s leading centres have dedicated transplant pharmacists and nephrologists who manage this. The availability of WHO GMP-certified generic immunosuppressants in India at USD 100 to USD 250 per month (vs USD 1,500 to USD 3,000 in the USA) also removes a major barrier to medication adherence for international patients returning home.
6. Patient Adherence to Medications
No matter how excellent the surgery, a kidney transplant fails if the recipient does not take their immunosuppressants reliably. Non-adherence is the leading preventable cause of late kidney rejection worldwide. India’s top centres invest in patient education, pharmacist counselling, and remote monitoring support to minimise this risk.
7. Pre-Transplant Optimisation
Patients who enter transplant surgery in the best possible health have the best outcomes. India’s comprehensive pre-transplant evaluation (10 to 14 days) ensures that cardiac disease, infections, nutritional deficiencies, and other complicating conditions are identified and addressed before surgery takes place.
How India’s Kidney Transplant Success Rate Compares Globally
| Country / Region | 1-Year Success Rate & Context |
|---|---|
| India (JCI-accredited, high-volume centres) | 92–96% (living donor), 85–90% (deceased donor). Matches global benchmarks at a fraction of Western costs. |
| United States (UNOS) | 94–96% (living donor), 90–93% (deceased donor). Highest global standards but costs $150,000–$400,000. |
| United Kingdom (NHS) | 94–96% (living donor), 92–95% (deceased donor). Free on NHS but 2.5–3 year wait for deceased donor. |
| Germany | 93–95% (living donor), 88–92% (deceased donor). High quality but expensive with long wait times. |
| Turkey | 88–92% (living donor). Costs $20,000–$35,000. Lower volume than India’s top centres. |
| Global Benchmark (ISN Global Atlas) | 90–95% (living donor, 1 year). India’s top centres meet or exceed this. |
| Key Conclusion | India’s top transplant centres deliver outcomes equivalent to the US and UK — the advantage is cost, not quality. |
What Happens If the Kidney is Rejected?
Rejection does not automatically mean failure. The word ‘rejection’ is frightening, but in practice, the vast majority of rejection episodes, particularly acute rejection, are successfully treated when detected early. Here is what patients need to understand:
Types of Kidney Transplant Rejection
- Hyperacute Rejection (minutes)
• Very rare due to modern crossmatch testing
• Happens immediately if antibodies exist
• Prevented before transplant - Acute Rejection (days–weeks)
• Occurs in ~10–20% in first year
• Detected by rising creatinine + biopsy
• 80%+ cases reversible with treatment - Antibody-Mediated Rejection (AMR)
• Caused by donor-specific antibodies
• Treated with plasmapheresis, IVIG, rituximab
• Needs specialist care - Chronic Rejection (months–years)
• Slow loss of kidney function
• Leading cause of long-term failure
• Managed with medicines + lifestyle control
How Hospitals Detect Early
- Frequent blood tests (weekly/bi-weekly early on)
- Monitor creatinine & drug levels
- Biopsy if any issue suspected
- Early detection = high success rates
Understanding Graft Survival vs Patient Survival
1. Graft Survival Rate
The percentage of transplanted kidneys still functioning at a given time.
This reflects the success of the transplant itself.
A patient may still be alive even if the graft fails and dialysis is required again.
2. Patient Survival Rate
The percentage of transplant patients still alive at a given time.
This includes patients even if the transplanted kidney stops working.
Typically higher than graft survival rates.
Why This Matters for International Patients
- Always evaluate both metrics, not just one
- Some centres may have high patient survival but lower graft survival
- The best hospitals maintain strong outcomes in both
Kidney Transplant Outcomes in India
- Graft Survival (1 year): 92–96%
- Patient Survival (1 year): 95–98%
- Reported by leading JCI-accredited hospitals in India and supported by published clinical data
How Shifam Health Helps You Choose the Right Centre for the Best Outcomes
Success rates are not uniform across all hospitals in India. Choosing the right centre is the most important factor you can control. Shifam Health helps you make that choice correctly.
- Case review and hospital matching: We share your reports with our partner transplant nephrologist who reviews your specific case, including your age, cause of kidney failure, donor’s blood group and relationship, and any complicating factors. We then match you with the hospital and surgeon whose specific expertise and success rate data are most relevant to your situation.
- ABO compatibility assessment: We determine whether your donor is standard compatible or requires the ABO-incompatible desensitisation protocol. We match you to the centers with the strongest ABO-incompatible track records (Apollo, Medanta, CMC Vellore) where clinically indicated.
- Transparent written cost estimate: All-inclusive cost breakdown in your currency before you travel. No financial surprises on arrival.
- Legal documentation support: Complete guidance through all THOTA Authorization Committee documents including relationship proof, affidavits, and embassy no-objection letters.
- In-hospital coordination: Our team liaises with the transplant coordinator throughout your evaluation, surgery, and recovery. We attend key consultations and ensure nothing falls through the cracks.
- Post-transplant medication guidance: We advise you on sourcing WHO GMP-certified generic immunosuppressants from India at USD 100 to USD 250 per month, saving USD 1,200 to USD 30,000 per year compared to sourcing them in the USA or South Africa.
- Local nephrology connection: Before you leave India, we connect you with a nephrologist in your home country who can provide ongoing creatinine monitoring and manage any complications, supporting the long-term success of your transplant.
Frequently Asked Questions (FAQs)
What is the kidney transplant success rate in India in 2026?
The one-year success rate for living donor kidney transplants at India’s JCI-accredited centres is 92 to 96 percent. Deceased donor transplants have an 85 to 90 percent one-year success rate. At five years, living donor graft survival is 75 to 85 percent. These figures match published ISN global benchmarks.
Which Indian hospital has the highest kidney transplant success rate?
Manipal Hospitals reports 97 percent for pediatric cases. Apollo Chennai reports over 95 percent one-year patient survival. All three are among the most credible published outcomes in India.
Is the kidney transplant success rate in India as good as in the USA or UK?
Yes, at JCI-accredited high-volume centres. India’s 92 to 96 percent one-year living donor success rate sits within the same range reported by UNOS in the USA (94 to 96 percent) and NHSBT in the UK (94 to 96 percent), at 70 to 95 percent lower cost.
What is the kidney transplant success rate for patients over 60 in India?
Patients aged 50 to 64 achieve 88 to 93 percent one-year graft survival. Patients over 65 achieve 82 to 88 percent.
What is the main cause of kidney transplant failure in India?
Chronic rejection, caused by long-term immune-mediated injury, is the leading cause of late graft failure. In the short term, infection and acute rejection are the main risks.
How can I find out the success rate of a specific Indian hospital before travelling?
Contact Shifam Health. We provide verified, hospital-specific success rate information based on published data and our direct experience with each centre, so you can compare outcomes before making your decision. Our consultation is free of charge.
Important
- Kidney Transplant in India: Complete 2026 Guide
- Kidney Transplant Cost in India by Country: 2026 Guide
- How to get Indian Medical Visa?
- Apollo Hospitals Kidney Transplant Guide 2026
- Kidney Failure Treatment India: Dialysis, Transplant and CAPD
- Best Hospitals for Kidney Transplant in India
Conclusion
The data is clear. At India’s JCI-accredited, high-volume kidney transplant centres, success rates of 92 to 96 percent at one year for living donor transplants are not aspirational claims. They are published, peer-reviewed, internationally benchmarked outcomes that match what leading hospitals in the USA and UK consistently achieve.
The difference is that in India, these outcomes are available at USD 7,000 to USD 13,000 rather than USD 150,000 to USD 400,000, with no waiting list for living donor transplants, and with post-transplant medications available at USD 100 to USD 250 per month rather than USD 1,500 to USD 3,000.
Choosing the right hospital and the right transplant team is the most important decision you can make for your outcome. Shifam Health helps you make that decision based on verified data, not marketing claims. Contact us today for a free case review and a personalised recommendation.
| Get Your Free Kidney Transplant Case Review Send your kidney function reports and donor details. We respond within 24 hours with a personalized hospital recommendation and cost estimate. No charges. No obligation. www.shifamhealth.com | contact@shifamhealth.com | WhatsApp: +91 81785 95807 24/7 Support Available | Free Consultation | No Hidden Charges |
Popular Posts From Last Week
- April 24, 2026
- Areen Fatima
Every year, more than 200,000 people in India are diagnosed with end-stage kidney disease. Globally, the number runs…
- April 27, 2026
- Areen Fatima
The question every kidney failure patient and their family asks first is simple: how much does a kidney…
- April 27, 2026
- Areen Fatima
When a patient from Nigeria, Kenya, Zambia, Bangladesh, or the Middle East is told they need a kidney…
- April 29, 2026
- shifamhealth
In the United Kingdom, a patient diagnosed with end-stage liver disease faces an average NHS waiting time of…
- April 25, 2026
- Areen Fatima
When the kidneys stop working, life does not stop. But it does change dramatically. Kidney failure, also known…
- April 30, 2026
- shifamhealth
For any patient considering a kidney transplant abroad, one question matters above all others: what are the chances…